3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Renal Cell
2
Carcinoma, Hepatocellular
2
Thyroid cancer, follicular
1
Thyroid Neoplasms
1
Thyroid Cancer, Papillary
1
Non functioning pancreatic endocrine tumor
1
Neuroendocrine Tumors
1
Liver Neoplasms
1
Carcinoma, Medullary
1
Adenoma, Islet Cell
1
Adenocarcinoma, Follicular
1
Interventions
talquetamab
2
ulixertinib
1
trastuzumab biosimilar HLX02
1
trametinib
1
sapanisertib
1
relatlimab
1
pertuzumab
1
palbociclib
1
osimertinib
1
omipalisib
1
larotrectinib
1
ivosidenib
1
ipatasertib
1
fedratinib
1
erdafitinib
1
enasidenib
1
defactinib
1
dabrafenib
1
copanlisib
1
capivasertib
1
binimetinib
1
adavosertib
1
X-Rays
1
Trastuzumab
1
Sunitinib
1
Specimen Handling
1
PF-05280014
1
Ontruzant
1
Ogivri
1
Nuclear Medicine Department, Hospital
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has announcements
×
Hematologic Neoplasms
×
cabozantinib
×
Clear all
No trials found.